BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

9539

200519

SAKAR

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

SAKAR HEALTHCARE LIMITED performance

Today’s low

Today’s high

₹ 265.35 ₹ 290.00
₹ 271.56

52 week low

52 week high

₹ 210.10 ₹ 374.50
₹ 271.56

Open Price

₹ 284.00

Prev. Close

₹ 291.37

Volume (Shares)

21386.00

Total traded value

₹ 58.07

Upper Circuit

₹ 349.64

Lower Circuit

₹ 233.09

info

SAKAR HEALTHCARE LIMITED Share Price Update

As of the latest trading session, SAKAR HEALTHCARE LIMITED share price is currently at ₹ 271.56, which is down by ₹ -19.81 from its previous closing. Today, the stock has fluctuated between ₹ 265.35 and ₹ 290.00. Over the past year, SAKAR HEALTHCARE LIMITED has achieved a return of -22.55 %. In the last month alone, the return has been 15.66 %. Read More...

SAKAR HEALTHCARE LIMITED fundamentals


  • Market cap (Cr)

    590.64

  • P/E Ratio (TTM)

    40.11

  • Beta

    0.64

  • Book Value / share

    126.28

  • Return on equity

    5.36%

  • EPS (TTM)

    6.79

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    4.53

info icon alternate text
  • Market cap (Cr)

    0.0

  • P/E Ratio (TTM)

    0.0

  • Beta

    0.0

  • Book Value / share

    0.0

  • Return on equity

    0.0%

  • EPS (TTM)

    0.0

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    0.0

info icon alternate text

SAKAR HEALTHCARE LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 43.42
Operating Expense 38.19
Net Profit 4.53
Net Profit Margin (%) 10.43
Earnings Per Share (EPS) 2.08
EBITDA 12.01
Effective Tax Rate (%) 17.15
Particulars SEP 2024 (Values in Cr)
Revenue 42.78
Operating Expense 38.04
Net Profit 4.80
Net Profit Margin (%) 11.22
Earnings Per Share (EPS) 2.17
EBITDA 11.87
Effective Tax Rate (%) 6.06
Particulars JUN 2024 (Values in Cr)
Revenue 41.15
Operating Expense 36.91
Net Profit 2.41
Net Profit Margin (%) 5.85
Earnings Per Share (EPS) 1.10
EBITDA 11.16
Effective Tax Rate (%) 48.72
Particulars MAR 2024 (Values in Cr)
Revenue 43.06
Operating Expense 39.04
Net Profit 3.12
Net Profit Margin (%) 7.24
Earnings Per Share (EPS) 1.46
EBITDA 11.75
Effective Tax Rate (%) 34.79
Particulars DEC 2023 (Values in Cr)
Revenue 37.23
Operating Expense 34.44
Net Profit 2.07
Net Profit Margin (%) 5.56
Earnings Per Share (EPS) 0.98
EBITDA 9.23
Effective Tax Rate (%) 31.00
Particulars MAR 2024 (Values in Cr)
Revenue 153.35
Operating Expense 140.63
Net Profit 11.67
Net Profit Margin (%) 7.61
Earnings Per Share (EPS) 5.64
EBITDA 41.54
Effective Tax Rate (%) 26.60
Particulars MAR 2023 (Values in Cr)
Revenue 133.36
Operating Expense 121.15
Net Profit 12.76
Net Profit Margin (%) 9.56
Earnings Per Share (EPS) 6.58
EBITDA 37.82
Effective Tax Rate (%) 24.40
Particulars MAR 2022 (Values in Cr)
Revenue 128.23
Operating Expense 111.39
Net Profit 15.24
Net Profit Margin (%) 11.88
Earnings Per Share (EPS) 8.77
EBITDA 31.58
Effective Tax Rate (%) 19.83
Particulars MAR 2021 (Values in Cr)
Revenue 94.74
Operating Expense 82.67
Net Profit 10.69
Net Profit Margin (%) 11.28
Earnings Per Share (EPS) 6.88
EBITDA 23.78
Effective Tax Rate (%) 19.25
Particulars MAR 2020 (Values in Cr)
Revenue 82.98
Operating Expense 72.77
Net Profit 9.62
Net Profit Margin (%) 11.59
Earnings Per Share (EPS) 6.40
EBITDA 21.56
Effective Tax Rate (%) 21.25
Particulars MAR 2024 (Values in Cr)
Book Value / Share 118.41
ROE % 5.36
ROCE % 7.36
Total Debt to Total Equity 0.46
EBITDA Margin 27.09
Particulars MAR 2023 (Values in Cr)
Book Value / Share 91.04
ROE % 8.48
ROCE % 8.85
Total Debt to Total Equity 0.70
EBITDA Margin 28.35
Particulars MAR 2022 (Values in Cr)
Book Value / Share 74.45
ROE % 13.49
ROCE % 12.05
Total Debt to Total Equity 0.60
EBITDA Margin 24.63
Particulars MAR 2021 (Values in Cr)
Book Value / Share 63.04
ROE % 11.88
ROCE % 13.07
Total Debt to Total Equity 0.33
EBITDA Margin 25.09
Particulars MAR 2020 (Values in Cr)
Book Value / Share 54.35
ROE % 11.83
ROCE % 14.68
Total Debt to Total Equity 0.20
EBITDA Margin 25.99
Particulars MAR 2024 (Values in Cr)
Book Value / Share 118.44
ROE % 5.36
ROCE % 7.36
Total Debt to Total Equity 0.46
EBITDA Margin 27.09
Particulars MAR 2023 (Values in Cr)
Book Value / Share 91.09
ROE % 8.48
ROCE % 8.85
Total Debt to Total Equity 0.70
EBITDA Margin 28.35
Particulars MAR 2022 (Values in Cr)
Book Value / Share 74.50
ROE % 13.49
ROCE % 12.05
Total Debt to Total Equity 0.60
EBITDA Margin 24.63
Particulars MAR 2021 (Values in Cr)
Book Value / Share 63.04
ROE % 11.89
ROCE % 13.07
Total Debt to Total Equity 0.33
EBITDA Margin 25.10
Particulars MAR 2020 (Values in Cr)
Book Value / Share 54.35
ROE % 12.57
ROCE % 15.91
Total Debt to Total Equity 0.18
EBITDA Margin 25.99
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.46
Total Assets 388.65
Total Liabilities 388.65
Total Equity 262.33
Share Outstanding 21750000
Price to Book Ratio 3.11
Return on Assets (%) 3.00
Return on Capital (%) 3.52
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.09
Total Assets 336.33
Total Liabilities 336.33
Total Equity 173.34
Share Outstanding 19040000
Price to Book Ratio 2.20
Return on Assets (%) 3.79
Return on Capital (%) 4.48
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 267.76
Total Liabilities 267.76
Total Equity 127.46
Share Outstanding 17118000
Price to Book Ratio 1.81
Return on Assets (%) 5.66
Return on Capital (%) 7
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.08
Total Assets 177.79
Total Liabilities 177.79
Total Equity 98.45
Share Outstanding 15618000
Price to Book Ratio 1.79
Return on Assets (%) 6.00
Return on Capital (%) 7.71
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.29
Total Assets 115.03
Total Liabilities 115.03
Total Equity 81.31
Share Outstanding 14961000
Price to Book Ratio 0.92
Return on Assets (%) 8.36
Return on Capital (%) 10.03
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.46
Total Assets 388.74
Total Liabilities 388.74
Total Equity 262.41
Share Outstanding 21750000
Price to Book Ratio 3.11
Return on Assets (%) 3.00
Return on Capital (%) 3.52
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.09
Total Assets 336.42
Total Liabilities 336.42
Total Equity 173.43
Share Outstanding 19040000
Price to Book Ratio 2.20
Return on Assets (%) 3.79
Return on Capital (%) 4.48
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 267.84
Total Liabilities 267.84
Total Equity 127.53
Share Outstanding 17118000
Price to Book Ratio 1.81
Return on Assets (%) 5.69
Return on Capital (%) 7.02
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.08
Total Assets 177.80
Total Liabilities 177.80
Total Equity 98.46
Share Outstanding 15618000
Price to Book Ratio 1.79
Return on Assets (%) 6.01
Return on Capital (%) 7.71
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.29
Total Assets 115.12
Total Liabilities 115.12
Total Equity 81.31
Share Outstanding 14961000
Price to Book Ratio 0.92
Return on Assets (%) 8.35
Return on Capital (%) 10.02
Particulars MAR 2024 (Values in Cr)
Net Income 15.89
Cash from Operations 141.82
Cash from Investing -51.53
Cash from Financing 27.44
Net change in Cash 0.37
Free Cash Flow 201.38
Particulars MAR 2023 (Values in Cr)
Net Income 16.87
Cash from Operations 37.60
Cash from Investing -74.37
Cash from Financing 41.09
Net change in Cash 0.06
Free Cash Flow 119.80
Particulars MAR 2022 (Values in Cr)
Net Income 19.00
Cash from Operations 35.52
Cash from Investing -90.37
Cash from Financing 54.62
Net change in Cash -0.05
Free Cash Flow 133.05
Particulars MAR 2021 (Values in Cr)
Net Income 13.23
Cash from Operations 15.30
Cash from Investing -46.83
Cash from Financing 32.03
Net change in Cash -0.22
Free Cash Flow 62.13
Particulars MAR 2020 (Values in Cr)
Net Income 12.22
Cash from Operations 21.63
Cash from Investing -22.40
Cash from Financing 3.48
Net change in Cash -0.06
Free Cash Flow 43.68
Particulars MAR 2024 (Values in Cr)
Net Income 15.89
Cash from Operations 141.82
Cash from Investing -51.53
Cash from Financing 27.44
Net change in Cash 0.37
Free Cash Flow 201.38
Particulars MAR 2023 (Values in Cr)
Net Income 16.87
Cash from Operations 37.60
Cash from Investing -74.37
Cash from Financing 41.09
Net change in Cash 0.06
Free Cash Flow 119.80
Particulars MAR 2022 (Values in Cr)
Net Income 19.00
Cash from Operations 35.59
Cash from Investing -90.40
Cash from Financing 54.56
Net change in Cash -0.05
Free Cash Flow 133.12
Particulars MAR 2021 (Values in Cr)
Net Income 13.24
Cash from Operations 15.31
Cash from Investing -46.83
Cash from Financing 32.03
Net change in Cash -0.21
Free Cash Flow 62.14
Particulars MAR 2020 (Values in Cr)
Net Income 12.22
Cash from Operations 21.56
Cash from Investing -22.33
Cash from Financing 3.48
Net change in Cash -0.07
Free Cash Flow 43.53
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 19.60 1.99 279.41 34.11 / 77.70
BLISS GVS PHARMA LTD 119.00 15.60 1.24 1253.91 92.25 / 184.95
CIPLA LTD 1549.65 25.08 4.41 125155.99 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 260.70 21.60 2.64 767.27 145.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 21.96 6.19 279.41 34.11 / 77.70
AMRUTAJAN HEALTH LTD 692.80 40.61 6.72 2002.93 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8665.50 129.24 31.88 21663.75 5000.00 / 9199.00
BLISS GVS PHARMA LTD 119.00 15.45 1.22 1253.91 92.25 / 184.95

SAKAR HEALTHCARE LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
271.56 -6.79 redarrow
red-green-graph indicator
11 Bearish
5 Bullish
  • 5 Days 285.60
  • 26 Days 269.90
  • 10 Days 284.10
  • 50 Days 265.20
  • 12 Days 282.00
  • 100 Days 273.10
  • 20 Days 273.90
  • 200 Days 289.30
290.34 PIVOT

First Support

286.43

First Resistance

295.28

Second Support

281.49

Second Resistance

299.19

Third Support

277.58

Third Resistance

304.13

RSI

51.07

ADX

23.47

MACD

12.16

Williams % R

-54.16

Commodity Channel Index (CCI)

21.13

Date

2025-04-30

Week

11047.00

Same Day

11345.00

Month

18425.00

1 Year

0.65

3 Year

0.83

Over 1 Month

15.66%

down

Over 1 Year

-22.55%

down

Over 3 Months

-0.74%

down

Over 3 Years

26.21%

down

Over 6 Months

-11.80%

down

Over 5 Years

39.63%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

SAKAR HEALTHCARE LIMITED shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
32.81%
Promoter Holdings
53.58%
FII
13.6%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category

News

Left Arrow
Right Arrow

SAKAR HEALTHCARE LIMITED corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

SAKAR HEALTHCARE LIMITED Share Price

Sakar Healthcare Limited was incorporated as a Private Limited Company under the name 'Sakar Healthcare Private Limited on 26th March 2004. Subsequently, the Company was converted into Public Limited Company on March 27, 2015 and the name of the Company was changed to 'Sakar Healthcare Limited. The Company is promoted by Sanjay Shah, Rita Shah and Aarsh Shah.

The Company is engaged in manufacturing of Pharmaceutical products providing Liquid Orals, Cephalosporin Tablet, Capsule, Dry Powder Syrup, Dry Powder Injections, Liquid Injectables (SVP) in Ampoules and Vials & Lyophilized Injections and Oral Solid Dossages. It manufactures and markets pharmaceutical formulations relating to analgesics, anti coagulants, anti malarial, anti spasmodic, antianemics, antibiotics, anti-emetics, anti-histamines, bronchodilators, corticosteroids, cough and cold preparations, multivitamins, etc.

The Company operates as contract development and manufacturing organisation (CDMO), being the EU GMP approved CMO for leading multinational pharmaceutical companies.Their 4 manufacturing facilities located at Changodar, Ahmedabad, Gujarat. have been approved by various international regulatory authorities and certified by ISO 9001:2008 (BVQI), WHO-GMP, CGMP & National Drug Authority, and it has obtained certain drug specific registrations from the relevant authorities in countries such as Uganda, Kenya, Yemen, Ethiopia, Congo, Ghana, Zimbabwe, Namibia, Nigeria, Cote d'ivoire.

In 2005, the Company started commercial production for Plant - 1 which was established for production of Liquid Orals; in 2007, it started exporting its products overseas; started commercial production for Plant - 2 which was established for production of Beta Lactum Tablet and Capsules and Dry Syrup B-lactum. / Sachet in 2008. Further, it started commercial production for Plant - 3 which was established for production of Liquid Injectibles (SVP) - Ampoules and Liquid Injectibles (SVP) - Vials.

In 2012, it started commercial production for Plant - 4 which was established for production of Dry Powder Injection. In 2017, it started Lyophilised injection product commercialisation.

In 2020, the Company received EU GMP certification for SVP unit manufacturing liquid and Lyophilised injections. In 2021, the Oncology Unit started operations in Bavla location. In 2022-23, the Company started commercialization with Oncology product post receiving WHO GMP certification.

Parent organization Indian Private
NSE symbol SAKAR
Founded 2004
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Sakar Healthcare Ltd?

Answer Field

The share price of Sakar Healthcare Ltd for NSE is ₹ 271.56 and for BSE is ₹ 0.00.

What is the Market Cap of Sakar Healthcare Ltd?

Answer Field

The market cap of Sakar Healthcare Ltd for NSE is ₹ 5,90.64 Cr. and for BSE is ₹ 0.0 Cr. as of now.

What is the 52 Week High and Low of Sakar Healthcare Ltd?

Answer Field

The 52 Week High and Low of Sakar Healthcare Ltd for NSE is ₹ 374.50 and ₹ 210.10 and for BSE is ₹ 0.00 and ₹ 0.00.

How to Buy Sakar Healthcare Ltd share?

Answer Field

You can trade in Sakar Healthcare Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Sakar Healthcare Ltd?

Answer Field

The 1 year returns on the stock has been -22.55%.

What is the Current Share Price of Sakar Healthcare Ltd?

Answer Field

Sakar Healthcare Ltd share price is for NSE ₹ 271.56 & for BSE ₹ 0.00 as on Apr 30 2025 03:30 PM.

What is the Market Cap of Sakar Healthcare Ltd Share?

Answer Field

The market cap of Sakar Healthcare Ltd for NSE ₹ 5,90.64 & for BSE ₹ 0.0 as on Apr 30 2025 03:30 PM.

What is the P/E Ratio of Sakar Healthcare Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM the price-to-earnings (PE) ratio for Sakar Healthcare Ltd share is 40.11.

What is the PB ratio of Sakar Healthcare Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM, the price-to-book (PB) ratio for Sakar Healthcare Ltd share is 126.28.

How to Buy Sakar Healthcare Ltd Share?

Answer Field

You can trade in Sakar Healthcare Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Sakar Healthcare Ltd Share on Bajaj Broking App?

Answer Field

To buy Sakar Healthcare Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Sakar Healthcare Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|